You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hematopoiesis

Showing 1 - 25 of 388
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

Not yet recruiting
  • Immune System Diseases
  • +15 more
  • observational cohort study
  • (no location specified)
Jul 23, 2023

Cardiovascular Disease in Hodgkin Lymphoma Survivors

Not yet recruiting
  • Hodgkin Lymphoma
  • +3 more
  • Patient Self Reporting
  • +2 more
  • (no location specified)
Jan 20, 2023

Patients With Myocardial Infarction

Not yet recruiting
  • To Investigate the Effect of CHIP on Renal Insufficiency in AMI Patients
  • No intervention
  • (no location specified)
Nov 27, 2023

Clonal Hematopoiesis of Indeterminate Potential in Non-ischemic

Completed
  • Heart Failure With Reduced Ejection Fraction
    • Seoul, Korea, Republic of
      Severance hospital
    Jul 31, 2023

    Coronary Heart Disease, Clonal Hematopoiesis of Indeterminate Potential (CHIP) Trial (MAS825, MAS825 Placebo, DFV890)

    Not yet recruiting
    • Coronary Heart Disease
    • Clonal Hematopoiesis of Indeterminate Potential (CHIP)
    • (no location specified)
    Oct 24, 2023

    Venous Thromboses, Thromboembolic Disease, Neutrophil Extracellular Trap Formation Trial in Bordeaux (Additional blood sampling)

    Not yet recruiting
    • Venous Thromboses
    • +3 more
    • Additional blood sampling
    • Bordeaux, France
    • +7 more
    Jan 24, 2023

    CHIP in Endothelial Dysfunction Associated With HEpEF

    Not yet recruiting
    • Heart Failure With Preserved Ejection Fraction
      • (no location specified)
      Apr 12, 2023

      CHIP/CCUS Natural History Protocol

      Recruiting
      • Clonal Hematopoiesis of Indeterminate Potential
      • Clonal Cytopenia of Undetermined Significance
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 20, 2022

        Metabolic Profiling of Hematopoietic Stem Cells in Clonal

        Recruiting
        • Osteoporosis
        • +4 more
        • Blood and bone marrow cell collection
        • Bonheiden, België, Belgium
          Imelda Hospital
        Feb 10, 2022

        Clonal Hematopoiesis of Indeterminate Potential in Venous

        Active, not recruiting
        • Venous Thromboembolism
          • Nîmes, France
            CHU de Nimes
          Jan 24, 2022

          Myocardial Infarction Trial in Pessac (Specific blood sampling)

          Completed
          • Myocardial Infarction
          • Specific blood sampling
          • Pessac, France
            Bordeaux University Hospital
          Feb 21, 2022

          PTSD, Trauma, Healthy Trial in Boston, New York (fluorodeoxyglucose (FDG)-PET/MRI)

          Recruiting
          • PTSD
          • +2 more
          • fluorodeoxyglucose (FDG)-PET/MRI
          • Boston, Massachusetts
          • +1 more
          Aug 29, 2022

          Clonal Hematopoiesis of Indeterminate Potential and Accelerated

          Completed
          • Systemic Lupus Erythematosus
            • Paris, France
              Hôpital Bichat
            Nov 25, 2021

            Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors

            Active, not recruiting
            • Cancer
            • Monitoring of ARCH variants
            • Toronto, Ontario, Canada
              Princess Margaret Cancer Centre
            Dec 6, 2021

            Aging, Geriatric Syndromes and Clonal Hematopoiesis

            Recruiting
            • Geriatrics
            • +3 more
            • Cognitive Assessment
            • +16 more
            • Saint Louis, Missouri
              Washington University School of Medicine
            Apr 18, 2022

            Pulmonary Embolism, Hematopoiesis Trial in Amiens (blood sample)

            Recruiting
            • Pulmonary Embolism
            • Hematopoiesis
            • blood sample
            • Amiens, France
              CHU Amiens
            Jul 20, 2021

            ACS, Clonal Hematopoiesis of Indeterminate Potential, Smoking Cessation Trial in Shenyang (clonal hematopoiesis of indeterminate

            Not yet recruiting
            • ACS
            • +2 more
            • clonal hematopoiesis of indeterminate potential
            • Shenyang, Liaoning, China
              General Hospital of Shenyang Military Region
            Aug 2, 2021

            Chemotherapy-Related Complications

            Recruiting
            • Lymphoma
            • Chemotherapeutic Toxicity
            • Blood test for determination of CHIP
            • Toronto, Ontario, Canada
              Sunnybrook Health Sciences Centre
            Aug 3, 2022

            MDS Trial in Dresden, Leipzig (Observational)

            Recruiting
            • Myelodysplastic Syndromes
            • Observational
            • Dresden, Germany
            • +1 more
            Aug 10, 2021

            Li-Fraumeni Syndrome, TP53 Gene Mutation, Hereditary Cancer Syndrome Trial in Boston (Data and Specimen Collection)

            Recruiting
            • Li-Fraumeni Syndrome
            • +4 more
            • Data and Specimen Collection
            • Boston, Massachusetts
            • +2 more
            Jan 23, 2023

            Atherosclerosis, Coronary, Emotional Stress, Inflammation Trial in Seoul (OCT-FLIM (optical coherence tomography-fluorescence

            Recruiting
            • Atherosclerosis, Coronary
            • +7 more
            • OCT-FLIM (optical coherence tomography-fluorescence life time)
            • Seoul, Korea, Republic of
              Korea University Guro Hospital
            Aug 22, 2022

            Severe/Moderate Coronavirus, Chronic Myelomonocytic Leukemia, MDS Trial in Villejuif (Blood samples)

            Not yet recruiting
            • Severe/Moderate Coronavirus
            • +3 more
            • Blood samples
            • Villejuif, France
              Gustave Roussy Institut
            Dec 20, 2021

            Glioblastoma Multiforme Trial in Cleveland (biological, drug, other, procedure, radiation)

            Active, not recruiting
            • Glioblastoma Multiforme
            • MGMTP140K-encoding retroviral vector
            • +6 more
            • Cleveland, Ohio
              University Hospitals Cleveland Medical Center, Case Comprehensiv
            May 6, 2022

            Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

            Not yet recruiting
            • Glioblastoma Multiforme
            • +3 more
            • P140K-MGMT
            • +5 more
            • Bethesda, Maryland
            • +1 more
            Jul 4, 2022

            Healthy Volunteers of Fanconi Anemia, Myeloproliferative

            Completed
            • Chronic Myeloproliferative Disorders
            • +3 more
            • microarray analysis
            • +8 more
            • Portland, Oregon
              Knight Cancer Institute at Oregon Health and Science University
            Jun 30, 2022